FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/01/022915 [Registered on: 22/01/2020] Trial Registered Prospectively
Last Modified On: 07/01/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison between hourly intermittent Epidural bolus and continuous epidural infusion of 0.1% Levobupivacaine AND Fentanyl for analgesia in labor. 
Scientific Title of Study   Comparison between intermittent Epidural bolus and continuous Epidural infusion of 0.1% levobupivacaine and fentanyl combination for labor analgesia. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Surinder kaur 
Designation  Junior Resident 
Affiliation  Government Medical College and Rajindra hospital 
Address  Department of Anaesthesia Government Medical College and Rajindra hospital, Patiala

Patiala
PUNJAB
144202
India 
Phone  9915176132  
Fax    
Email  dr_surinder18@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Tripat Kaur Bindra 
Designation  Professor 
Affiliation  Government Medical College and Rajindra hospital 
Address  Department of Anaesthesia Government Medical College and Rajindra hospital, Patiala.

Patiala
PUNJAB
147001
India 
Phone  9501017040  
Fax    
Email  tripat_noori@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Tripat Kaur Bindra 
Designation  Professor 
Affiliation  Government Medical College and Rajindra hospital 
Address  Department of Anaesthesia Government Medical College and Rajindra hospital, Patiala

Patiala
PUNJAB
147001
India 
Phone  9501017040  
Fax    
Email  tripat_noori@yahoo.co.in  
 
Source of Monetary or Material Support  
Government medical college and rajindra hospital,Patiala(Punjab) 
 
Primary Sponsor  
Name  Department of anaesthesiology and intensive care 
Address  Government college and rajindra hospital ,patiala 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Surinder kaur  Government Medical college and Rajindra hospital  Department of Anaesthesia and intensive care, Government medical college and Rajindra hospital,Patiala
Patiala
PUNJAB 
9915176132

dr_surinder18@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Government Medical college,Patiala  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O00-O9A||Pregnancy, childbirth and the puerperium,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Epidural labor analgesia  Intermittent epidural bolus an hourly versus continuous epidural infusion of 0.1% levobupivacaine and fentanyl 2 mcg/ml combination for labor analgesia till the time of delivery of the baby. 
Comparator Agent  not applicable  not applicable 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  parturient with single pregnancy.
Cervical dilatation of 3-5 cm.
Cephalic presentation
Gestation >37 weeks 
 
ExclusionCriteria 
Details  Breech presentation
Antepartum Haemorrhage
Severe Pre eclampsia
Multiple pegnancies
Cephalopelvic disproportion
Bleeding disorders
Decreased platelet counts
Sepsis
Aortic stenosis
Diabetes
Fetal distress
Imminent delivery
spinal column deformity
Spine surgery
Contraindication to epidural analgesia
History of anaphylaxis to local anaeshetics and allergy to drug to be administered. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Level of analgesia  Till the time of delivery of the baby. 
 
Secondary Outcome  
Outcome  TimePoints 
Total drug requirement ,Mode of delivery, Postpartum complications  48 hours after delivery. 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   27/01/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   The present randomized study will be conducted on 80 women  in labour, belonging to ASA grade I or II,  more than 36 weeks of gestation, at 3- 5 cm cervical dilatation, single pregnancy  with cephalic presentation, who requested for labour analgesia at Rajindra Hospital, Patiala. The patients will be allocated randomly to 2 groups. Group A: Parturient will be given 10 ml of 0.1% Levobupivacaine (plain ) with Fentanyl 50 mcg  and then 8 ml of  0.1% Levobupivacaine (plain ) and fentanyl 2 mcg / ml  solution as epidural bolus every hour. Group B: Parturient will be given 10 ml of 0.1% levobupivacaine (plain ) with fentanyl 50 mcg and then 8 ml /hour of 0.1% Levobupivacaine (plain ) with fentanyl 2 mcg / ml as continuous epidural infusion. After administration of the drug,pain intensity, level of sensory  block, degree of motor block, total drug requirement ,hemodynamic variables, mode of delivery, duration of second stage,neonatal outcome and side effects and post partum complications will be compared in both the groups. 
Close